Inuvo price target lowered to $12 from $15 at Maxim

Maxim analyst Jack Vander Aarde lowered the firm’s price target on Inuvo (INUV) to $12 from $15 but keeps a Buy rating on the shares after its Q2 results. The company has added 18 new self-serve clients during the quarter with lower average selling price but higher margin and 4 IntentKey managed service clients, which represent a small portion of revenue but have very high-margins that should be beneficial long-term as the offerings expand, the analyst tells investors in a research note.